A Lloyd

Summary

Affiliation: Oxford Outcomes
Country: UK

Publications

  1. doi request reprint Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™)
    Andrew Lloyd
    Oxford Outcomes an Icon plc Company, Seacourt Tower, Oxford, OX1 0JJ, UK
    Qual Life Res 23:449-58. 2014
  2. doi request reprint Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations
    Andrew Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Patient 4:247-57. 2011
  3. pmc Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
    Mike Thomas
    Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, UK
    BMC Pulm Med 9:1. 2009
  4. doi request reprint A valuation of infusion therapy to preserve islet function in type 1 diabetes
    Andrew Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Value Health 13:636-42. 2010
  5. doi request reprint Reimbursement agency requirements for health related quality-of-life data: a case study
    Andrew Lloyd
    Oxford Outcomes Ltd, Seacourt Tower, West Way, Oxford OX2 0JJ, UK
    Expert Rev Pharmacoecon Outcomes Res 9:527-37. 2009
  6. doi request reprint Health state utility scores for cancer-related anemia through societal and patient valuations
    Andrew Lloyd
    Oxford Outcomes Ltd, Seacourt Tower, Oxford, UK
    Value Health 11:1178-85. 2008
  7. doi request reprint Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus
    Andrew Lloyd
    United BioSource Corporation, London, United Kingdom
    Clin Ther 33:1258-67. 2011
  8. doi request reprint Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences
    Andrew Lloyd
    Oxford Outcomes Ltd
    Int J Technol Assess Health Care 27:215-23. 2011
  9. doi request reprint Health utility values associated with diabetic retinopathy
    A Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Diabet Med 25:618-24. 2008
  10. ncbi request reprint Preferences and utilities for the symptoms of moderate to severe allergic asthma
    Andrew Lloyd
    Oxford Outcomes Ltd, West Way, Oxford, OX2 0JJ, UK
    Eur J Health Econ 9:275-84. 2008

Collaborators

Detail Information

Publications17

  1. doi request reprint Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™)
    Andrew Lloyd
    Oxford Outcomes an Icon plc Company, Seacourt Tower, Oxford, OX1 0JJ, UK
    Qual Life Res 23:449-58. 2014
    ..This study aimed to develop an algorithm for estimating utilities from the short bowel syndrome health-related quality of life scale (SBS-QoL™)...
  2. doi request reprint Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations
    Andrew Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Patient 4:247-57. 2011
    ..Responder status has been associated with a small gain in health-related quality of life (HR-QOL) [or utility, as measured using the generic QOL measure EQ-5D] of 0.06 (on a scale from 0 being dead to 1.0 being full health)...
  3. pmc Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
    Mike Thomas
    Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, UK
    BMC Pulm Med 9:1. 2009
    ..Our objective was to evaluate impact on asthma control of inhaler device switching without an accompanying consultation in general practice...
  4. doi request reprint A valuation of infusion therapy to preserve islet function in type 1 diabetes
    Andrew Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Value Health 13:636-42. 2010
    ..The present study was designed to capture UK (English and Scottish) preference weights for the process of undergoing infusion therapy and the likely outcomes of treatment for children (8-12 years), adolescents (13-17 years), and adults...
  5. doi request reprint Reimbursement agency requirements for health related quality-of-life data: a case study
    Andrew Lloyd
    Oxford Outcomes Ltd, Seacourt Tower, West Way, Oxford OX2 0JJ, UK
    Expert Rev Pharmacoecon Outcomes Res 9:527-37. 2009
    ..This may, thus, facilitate consistent and rational Health Technology Assessment decision making...
  6. doi request reprint Health state utility scores for cancer-related anemia through societal and patient valuations
    Andrew Lloyd
    Oxford Outcomes Ltd, Seacourt Tower, Oxford, UK
    Value Health 11:1178-85. 2008
    ..Fatigue is recognized as the most serious complication of chemotherapy for the majority of patients. This study aims to determine preferences and utility values for health state descriptions of anemia associated with cancer treatment...
  7. doi request reprint Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus
    Andrew Lloyd
    United BioSource Corporation, London, United Kingdom
    Clin Ther 33:1258-67. 2011
    ..The current evidence base demonstrates the efficacy of treatments, but it is critical also to understand patient preferences regarding treatments and how they are determined...
  8. doi request reprint Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences
    Andrew Lloyd
    Oxford Outcomes Ltd
    Int J Technol Assess Health Care 27:215-23. 2011
    ..Recently a transdermal delivery system has been developed which can allow symptom control all day long but with greater dosing flexibility. This study explored the parents' preferences regarding oral and transdermal therapy...
  9. doi request reprint Health utility values associated with diabetic retinopathy
    A Lloyd
    Oxford Outcomes Ltd, Oxford, UK
    Diabet Med 25:618-24. 2008
    ..The present study was designed to estimate utility loss using multiple methods...
  10. ncbi request reprint Preferences and utilities for the symptoms of moderate to severe allergic asthma
    Andrew Lloyd
    Oxford Outcomes Ltd, West Way, Oxford, OX2 0JJ, UK
    Eur J Health Econ 9:275-84. 2008
    ..The aim of this study was to elicit societal preferences for the symptom burden associated with moderate to severe allergic asthma...
  11. pmc Health state utilities for metastatic breast cancer
    A Lloyd
    United BioSource Corporation, 20 Bloomsbury Square, London WC1A 2NS, UK
    Br J Cancer 95:683-90. 2006
    ..This may be the largest preference study in breast cancer designed to survey a representative general public sample...
  12. ncbi request reprint Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
    A Lloyd
    Center for Health Outcomes Research, United BioSource Corporation, 20 Bloomsbury Square, London, WC1A 2NS, UK
    Prostate Cancer Prostatic Dis 11:153-9. 2008
    ..Survival gains should be considered alongside side effects when discussing treatment options in metastatic disease...
  13. doi request reprint Elicitation of health state utilities in neuroendocrine tumours
    P Swinburn
    Oxford Outcomes, an ICON plc company, Seacourt Tower, West Way, Oxford, OX2 0JJ, UK
    J Med Econ 15:681-7. 2012
    ..The aim of the study was to elicit utilities for health state vignettes describing the burdens associated with receiving therapy for advanced NETs...
  14. ncbi request reprint Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
    A Lloyd
    IMSWorld Publications Ltd, London, UK
    Curr Med Res Opin 25:599-605. 2009
    ....
  15. doi request reprint The measurement of chronic pain and health-related quality of life following inguinal hernia repair: a review of the literature
    P van Hanswijck de Jonge
    United BioSource Corporation, 20 Bloomsbury Square, London, WC1A 2NS, UK
    Hernia 12:561-9. 2008
    ..Reference lists were scanned for additional studies. Only studies examining chronic (>3 months) post-operative inguinal hernia repair (IHR)-related pain were included in this review...
  16. ncbi request reprint A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial
    A Lloyd
    Fourth Hurdle Consulting Ltd, London, UK
    Curr Med Res Opin 24:1279-84. 2008
    ..This study presents a cost-minimisation analysis of moxifloxacin compared to combination treatment with levofloxacin and ceftriaxone in patients hospitalised with community-acquired pneumonia (CAP) in Germany...
  17. pmc Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery
    H Eleftheriadis
    Sussex Eye Hospital, Eastern Road, Brighton BN2 5BF, UK
    Br J Ophthalmol 86:299-305. 2002
    ..To study the long term toxic effects of intraocular benzalkonium chloride (BAC)...